Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latvian drug prices could see a rise

This article was originally published in Scrip

Executive Summary

There are still question marks on whether drug prices in Latvia will rise. Earlier this summer, the government abolished the "pharmacist owns pharmacy" rule, part of the national law on medicines adopted in 2001 and amended this year. Some quarters believed the rule could lead to an increase in drug prices because of likely pharmacy closures, but this fear has now lessened (scripintelligence.com, 19 August 2010).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010011

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel